Clearing the way for tau immunotherapy in Alzheimer's disease

被引:15
|
作者
Herrmann, Abigail
Spires-Jones, Tara [1 ,2 ]
机构
[1] Univ Edinburgh, Ctr Cognit & Neural Syst, Edinburgh, Midlothian, Scotland
[2] Univ Edinburgh, Euan MacDonald Ctr Motorneurone Dis Res, Edinburgh, Midlothian, Scotland
关键词
TANGLE MOUSE MODEL; NEUROFIBRILLARY TANGLES; PASSIVE-IMMUNIZATION; PATHOLOGY; ANTIBODIES; BRAIN; MICE; TARGET;
D O I
10.1111/jnc.12845
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Read the full article Tau-targeting passive immunization modulates aspects of pathology in tau transgenic mice' on page 135.
引用
收藏
页码:1 / 4
页数:4
相关论文
共 50 条
  • [21] Immunotherapy for Alzheimer's disease
    Morgan, D.
    JOURNAL OF INTERNAL MEDICINE, 2011, 269 (01) : 54 - 63
  • [22] Immunotherapy of Alzheimer's disease
    Nitsch, Roger M.
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 5 - 5
  • [23] Immunotherapy for Alzheimer's disease
    Schenk, D.
    Schroeter, S.
    Buttini, M.
    Grundman, M.
    Games, D.
    Seubert, P.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2006, 16 : S198 - S198
  • [24] Immunotherapy for Alzheimer's Disease
    Farlow, Martin R.
    Brosch, Jared R.
    NEUROLOGIC CLINICS, 2013, 31 (03) : 869 - +
  • [25] Immunotherapy of Alzheimer's disease
    Nitsch, Roger M.
    Hock, Christoph
    ALZHEIMER: 100 YEARS AND BEYOND, 2006, : 425 - +
  • [26] Immunotherapy for Alzheimer's disease
    Wisniewski, Thomas
    Goni, Fernando
    BIOCHEMICAL PHARMACOLOGY, 2014, 88 (04) : 499 - 507
  • [27] Alzheimer’s disease and immunotherapy
    Wei Qin
    Yana Pang
    Shuya Nie
    Meina Quan
    Jianping Jia
    Current Medicine, 3 (1):
  • [28] The immunotherapy of Alzheimer's disease
    Weksler M.E.
    Immunity & Ageing, 1 (1)
  • [29] Immunotherapy for Alzheimer's disease
    Wang, Weihua
    Fan, Liangfeng
    Xu, De'en
    Wen, Zhongmin
    Yu, Rong
    Ma, Quanhong
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2012, 44 (10) : 807 - 814
  • [30] Immunotherapy for Alzheimer's disease
    Solomon, Beka
    Frenkel, Dan
    NEUROPHARMACOLOGY, 2010, 59 (4-5) : 303 - 309